Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Biology (Basel) ; 11(4)2022 Mar 24.
Article in English | MEDLINE | ID: mdl-35453696

ABSTRACT

Numerous orchid species around the world have already been affected by the ongoing climate change, displaying phenological alterations and considerable changes to their distributions. The fly orchid (Ophrys insectifera L.) is a well-known and distinctive Ophrys species in Europe, with a broad distribution across the continent. This study explores the effects of climate change on the range of O. insectifera, using a species distribution models (SDMs) framework that encompasses different climatic models and scenarios for the near- and long-term future. The species' environmentally suitable area is projected to shift northwards (as expected) but downhill (contrary to usual expectations) in the future. In addition, an overall range contraction is predicted under all investigated combinations of climatic models and scenarios. While this is moderate overall, it includes some regions of severe loss and other areas with major gains. Specifically, O. insectifera is projected to experience major area loss in its southern reaches (the Balkans, Italy and Spain), while it will expand its northern limits to North Europe, with the UK, Scandinavia, and the Baltic countries exhibiting the largest gains.

2.
Ann Gen Psychiatry ; 21(1): 9, 2022 Mar 09.
Article in English | MEDLINE | ID: mdl-35264198

ABSTRACT

BACKGROUND: Wearing facemasks is of proven efficacy as a public health protective measure against COVID-19. Currently there are no observational data concerning the wearing of facemasks and the adherence to guidelines concerning their handling. METHODS: Registration of the way passers-by were wearing facemasks at 26 different locations of five major cities in Greece. The results were correlated with the rate of COVID-19 deaths in the region. RESULTS: In total, 119,433 passers-by were registered, 57,043 females (47.8%) and 62,390 males (52.2%). From the total sample, 81.1% were wearing the mask properly, 10.8% had their nose out, 6.2% were wearing it under the jaw, and 1.9% had no mask at all . There was a significant difference between males and females concerning any use of mask. Inappropriate use of was correlated with COVID-19 death rate in the studied region. CONCLUSION: Our findings suggest that under conditions of mandatory wearing and in central locations of major cities, during walking, proper use of masks is suboptimal, but still contributes with some protection. Fear and risk perception seem to be strong factors contributing to adherence to proper mask wearing.

3.
Blood ; 137(10): 1365-1376, 2021 03 11.
Article in English | MEDLINE | ID: mdl-32992344

ABSTRACT

Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain major stereotyped subsets often display remarkably consistent clinicobiological profiles, suggesting that the study of BcR immunoglobulin stereotypy in CLL has important implications for understanding disease pathophysiology and refining clinical decision-making. Nevertheless, several issues remain open, especially pertaining to the actual frequency of BcR immunoglobulin stereotypy and major subsets, as well as the existence of higher-order connections between individual subsets. To address these issues, we investigated clonotypic IGHV-IGHD-IGHJ gene rearrangements in a series of 29 856 patients with CLL, by far the largest series worldwide. We report that the stereotyped fraction of CLL peaks at 41% of the entire cohort and that all 19 previously identified major subsets retained their relative size and ranking, while 10 new ones emerged; overall, major stereotyped subsets had a cumulative frequency of 13.5%. Higher-level relationships were evident between subsets, particularly for major stereotyped subsets with unmutated IGHV genes (U-CLL), for which close relations with other subsets, termed "satellites," were identified. Satellite subsets accounted for 3% of the entire cohort. These results confirm our previous notion that major subsets can be robustly identified and are consistent in relative size, hence representing distinct disease variants amenable to compartmentalized research with the potential of overcoming the pronounced heterogeneity of CLL. Furthermore, the existence of satellite subsets reveals a novel aspect of repertoire restriction with implications for refined molecular classification of CLL.


Subject(s)
Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Gene Frequency , Gene Rearrangement , Humans , Somatic Hypermutation, Immunoglobulin
4.
Leuk Lymphoma ; 60(7): 1685-1692, 2019 07.
Article in English | MEDLINE | ID: mdl-30652530

ABSTRACT

Rituximab is known to affect T cell immune responses. We and others have reported expansions of T large granular lymphocytes (T-LGLs) in lymphoma patients after Rituximab. We report here the immunogenetic profiling of the T cell receptor (TR) gene repertoire in 14 patients who received Rituximab post allo-HCT and explore clinicobiological correlations. All experienced antigenic triggers, CMV, EBV re-activation and chronic GvHD and had been treated with Rituximab. Skewing of TRBV genes was observed: 3 TRBV genes accounted for half of the repertoire. Oligoclonal pattern with expanded clonotypes was common. Patients with oligoclonality exhibited frequently cGvHD. Longitudinal samples in one revealed distinct clonotypes, suggesting clonal drift. T-LGL leukemia of donor origin with mixed chimerism eventually developed. In conclusion, we report development of oligoclonal T-LGLs after Rituximab post allo-HCT, alluding to antigen selection. Persistence of this phenomenon likely reflects strong antigenic stimulation by viruses and/or cGVHD aggravated by Rituximab.


Subject(s)
Clonal Evolution , Gene Rearrangement, T-Lymphocyte/immunology , Graft vs Host Disease/drug therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Leukemia, Large Granular Lymphocytic/pathology , Receptors, Antigen, T-Cell, alpha-beta/immunology , Rituximab/adverse effects , Adolescent , Adult , Antineoplastic Agents, Immunological/adverse effects , Female , Follow-Up Studies , Gene Rearrangement, T-Lymphocyte/genetics , Graft vs Host Disease/etiology , Graft vs Host Disease/pathology , Hematologic Neoplasms/therapy , Humans , Leukemia, Large Granular Lymphocytic/chemically induced , Leukemia, Large Granular Lymphocytic/immunology , Male , Middle Aged , Prognosis , Retrospective Studies , Survival Rate , Transplantation, Homologous , Virus Activation/drug effects , Young Adult
5.
J Pathol ; 247(4): 416-421, 2019 04.
Article in English | MEDLINE | ID: mdl-30484876

ABSTRACT

The B cell receptor immunoglobulin (Ig) gene repertoires of marginal zone (MZ) lymphoproliferations were analyzed in order to obtain insight into their ontogenetic relationships. Our cohort included cases with MZ lymphomas (n = 488), i.e. splenic (SMZL), nodal (NMZL) and extranodal (ENMZL), as well as provisional entities (n = 76), according to the WHO classification. The most striking Ig gene repertoire skewing was observed in SMZL. However, restrictions were also identified in all other MZ lymphomas studied, particularly ENMZL, with significantly different Ig gene distributions depending on the primary site of involvement. Cross-entity comparisons of the MZ Ig sequence dataset with a large dataset of Ig sequences (MZ-related or not; n = 65 837) revealed four major clusters of cases sharing homologous ('public') heavy variable complementarity-determining region 3. These clusters included rearrangements from SMZL, ENMZL (gastric, salivary gland, ocular adnexa), chronic lymphocytic leukemia, but also rheumatoid factors and non-malignant splenic MZ cells. In conclusion, different MZ lymphomas display biased immunogenetic signatures indicating distinct antigen exposure histories. The existence of rare public stereotypes raises the intriguing possibility that common, pathogen-triggered, immune-mediated mechanisms may result in diverse B lymphoproliferations due to targeting versatile progenitor B cells and/or operating in particular microenvironments. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.


Subject(s)
Genes, Immunoglobulin/genetics , Lymphoma, B-Cell, Marginal Zone/genetics , Complementarity Determining Regions/genetics , Gene Rearrangement, B-Lymphocyte/genetics , Genes, Immunoglobulin Heavy Chain/genetics , Humans , Immunoglobulin Variable Region/genetics , Mutation/genetics , Receptors, Antigen, B-Cell/genetics , Tumor Microenvironment
6.
Leuk Lymphoma ; 58(12): 2926-2933, 2017 12.
Article in English | MEDLINE | ID: mdl-28535087

ABSTRACT

Chronic idiopathic neutropenia (CIN) is an acquired disorder of granulopoiesis characterized by female predominance and mostly uncomplicated course. Crucial to CIN pathophysiology is the presence of activated T lymphocytes with myelosuppressive properties in both peripheral blood (PB) and bone marrow (BM). We systematically profiled the T cell receptor beta chain (TRB) gene repertoire in CD8+ cells of 34 CIN patients through subcloning/Sanger sequencing analysis of TRBV-TRBD-TRBJ gene rearrangements. Remarkable repertoire skewing and oligoclonality were observed, along with shared clonotypes between different patients, alluding to antigen selection. Cross-comparison of our sequence dataset with public TRB sequence databases revealed that CIN may rarely share common immunogenetic features with other entities, however, the CIN TRB repertoire is largely disease-biased. Overall, these findings suggest that CIN may be driven by long-term exposure to a restricted set of specific CIN-associated antigens.


Subject(s)
Gene Expression Regulation , Neutropenia/etiology , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Cytotoxic/metabolism , Adult , Aged , Aged, 80 and over , Alleles , Chronic Disease , Female , Gene Rearrangement, beta-Chain T-Cell Antigen Receptor/genetics , HLA Antigens/genetics , Humans , Leukocyte Count , Male , Middle Aged , Mutation , Neutropenia/diagnosis , Neutropenia/metabolism , Receptors, Antigen, T-Cell, alpha-beta/metabolism , STAT3 Transcription Factor/genetics , Young Adult
8.
Clin Cancer Res ; 22(1): 167-74, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26338994

ABSTRACT

PURPOSE: The role of antigen(s) in shaping the T-cell repertoire in chronic lymphocytic leukemia, although relevant for understanding malignant cell interactions with cognate T cells, is largely unexplored. EXPERIMENTAL DESIGN: Here we profiled the T-cell receptor ß chain gene repertoire in 58 chronic lymphocytic leukemia patients, focusing on cases assigned to well-characterized subsets with stereotyped clonotypic B-cell receptor immunoglobulins, therefore those cases most evidently selected by antigen (subsets #1, #2, and #4). RESULTS: Remarkable repertoire skewing and oligoclonality were observed, and differences between subsets were noted regarding both T-cell receptor ß chain gene usage and the extent of clonality, with subset #2 being the least oligoclonal. Longitudinal analysis of subset #4 cases revealed that although the repertoire may fluctuate over time, certain clonotypes persist, thus alluding to persistent antigenic stimulation. Shared ("stereotyped") clonotypes were found between different patients, reflecting selection by common antigenic elements. Cross-comparison of our dataset with public databases showed that some T-cell clonotypes may have expanded secondary to common viral infections; however, the majority of clonotypes proved to be disease-specific. CONCLUSIONS: Overall, the T-cell receptor ß chain repertoire in chronic lymphocytic leukemia is likely shaped by antigen selection and the implicated antigenic elements may concern epitopes that also select the malignant B-cell progenitors or, more intriguingly, chronic lymphocytic leukemia-derived epitopes.


Subject(s)
Clonal Selection, Antigen-Mediated/immunology , Epitopes, T-Lymphocyte/immunology , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Aged , Aged, 80 and over , Case-Control Studies , Clonal Evolution/genetics , Databases, Genetic , Gene Rearrangement , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Middle Aged , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Antigen, T-Cell, alpha-beta/metabolism
9.
Clin Cancer Res ; 22(8): 2032-40, 2016 Apr 15.
Article in English | MEDLINE | ID: mdl-26647217

ABSTRACT

PURPOSE: Prompted by the extensive biases in the immunoglobulin (IG) gene repertoire of splenic marginal-zone lymphoma (SMZL), supporting antigen selection in SMZL ontogeny, we sought to investigate whether antigen involvement is also relevant post-transformation. EXPERIMENTAL DESIGN: We conducted a large-scale subcloning study of the IG rearrangements of 40 SMZL cases aimed at assessing intraclonal diversification (ID) due to ongoing somatic hypermutation (SHM). RESULTS: ID was identified in 17 of 21 (81%) rearrangements using the immunoglobulin heavy variable (IGHV)1-2*04 gene versus 8 of 19 (40%) rearrangements utilizing other IGHV genes (P= 0.001). ID was also evident in most analyzed IG light chain gene rearrangements, albeit was more limited compared with IG heavy chains. Identical sequence changes were shared by subclones from different patients utilizing the IGHV1-2*04 gene, confirming restricted ongoing SHM profiles. Non-IGHV1-2*04 cases displayed both a lower number of ongoing SHMs and a lack of shared mutations (per group of cases utilizing the same IGHV gene). CONCLUSIONS: These findings support ongoing antigen involvement in a sizable portion of SMZL and further argue that IGHV1-2*04 SMZL may represent a distinct molecular subtype of the disease.


Subject(s)
Alleles , Antigens/immunology , Lymphoma, B-Cell, Marginal Zone/genetics , Lymphoma, B-Cell, Marginal Zone/immunology , Receptors, Antigen, B-Cell/genetics , Splenic Neoplasms/genetics , Splenic Neoplasms/immunology , Amino Acid Motifs , Amino Acid Sequence , Amino Acid Substitution , Complementarity Determining Regions/chemistry , Complementarity Determining Regions/genetics , Gene Expression Profiling , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Humans , Immunoglobulin Heavy Chains/chemistry , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/chemistry , Immunoglobulin Variable Region/genetics , Lymphoma, B-Cell, Marginal Zone/pathology , Models, Biological , Mutation , Splenic Neoplasms/pathology , Transcriptome
10.
Am J Pathol ; 185(6): 1740-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25843681

ABSTRACT

To further our understanding about antigen involvement in mantle cell lymphoma (MCL), we analyzed the expression levels of activation-induced cytidine deaminase (AID), a key player in B-cell responses to antigen triggering, in 133 MCL cases; assessed the functionality of AID by evaluating in vivo class switch recombination in 52 MCL cases; and sought for indications of ongoing antigen interactions by exploring intraclonal diversification within 14 MCL cases. The AID full-length transcript and the most frequent splice variants (AID-ΔE4a, AID-ΔE) were detected in 128 (96.2%), 96 (72.2%), and 130 cases (97.7%), respectively. Higher AID full-length transcript levels were significantly associated (P < 0.001) with lack of somatic hypermutation within the clonotypic immunoglobulin heavy variable (IGHV) genes. Median AID transcript levels were higher in lymph node material compared to cases in which peripheral blood was analyzed, implying that clonal behavior is influenced by the microenvironment. Switched tumor-derived IGHV-IGHD-IGHJ transcripts were identified in 5 of 52 cases (9.6%), all of which displayed somatic hypermutation and AID-mRNA expression. Finally, although most cases exhibited low levels of intraclonal diversification, analysis of the mutational activity revealed a precise targeting of somatic hypermutation indicative of an active, ongoing interaction with antigen(s). Collectively, these findings strongly allude to antigen involvement in the natural history of MCL, further challenging the notion of antigen naivety.


Subject(s)
B-Lymphocytes/metabolism , Cytidine Deaminase/metabolism , Immunoglobulin Variable Region , Lymphoma, Mantle-Cell/metabolism , Somatic Hypermutation, Immunoglobulin , B-Lymphocytes/immunology , B-Lymphocytes/pathology , Humans , Lymphoma, Mantle-Cell/immunology , Lymphoma, Mantle-Cell/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...